Logo

Call us today 212-583-0100

ir@enzo.com    

  • Home
  • Corporate
    • Investor Information
    • About Us
    • Officers & Directors
    • Press Releases
    • Careers
  • Therapeutics
    • About ENZO Therapeutics
      • Overview
      • Our Mission
      • Our Strategy
      • Partnering
      • Maps and Directions
      • Contact Us
    • Therapeutic Market
      • Overview
      • Inflammatory Bowel Disease
      • Uveitis
      • HIV
      • Bone Disorders
      • Diabetes
    • Technologies
      • Immune Regulation
      • Gene Technology
      • Cell Signaling Modulation
    • Pipeline
      • Overview
      • Cell Signaling Modulation
        • Diabetes
        • Preclinical Studies for Bone Disorders
      • Immune Regulation
        • Alequel ™
        • Optiquel ™
      • Gene Technology
        • Stealth Vector™ HGTV43™
  • Clinical Labs
  • Life Sciences
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Nov 03, 2008 3:48pm EST

Enzo Biochem Details Advances in Understanding the Role Of NKT Killer Cells in Autoimmunity and Cancer at Liver Conference

Oct 14, 2008 4:15pm EDT

Enzo Biochem Reports Record Revenues and Significantly Improved Operating Results for Fiscal 2008

Oct 10, 2008 10:07am EDT

Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Year-End 2008 Results for October 15, 2008, at 8:30 AM E.T.

Sep 17, 2008 10:00am EDT

Enzo Biochem to Present at UBS 2008 Global Life Sciences Conference

Jun 09, 2008 4:10pm EDT

Enzo Biochem Reports Results for Third Quarter and Nine Months

Jun 04, 2008 12:13pm EDT

Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2008 Results for Tuesday June 10, 2008, at 8:30 AM E.T.

May 12, 2008 2:30pm EDT

Enzo Biochem to Present at Rodman & Renshaw Fifth Annual Global Healthcare Conference

May 09, 2008 9:10am EDT

Enzo Biochem Acquires BIOMOL International, Further Expanding Its Life Sciences Operations

Mar 11, 2008 4:15pm EDT

Enzo Biochem Reports Second Quarter and Six-Month Results

Mar 06, 2008 1:43pm EST

Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2008 Results for Wednesday March 12, 2008, at 8:30 AM E.T.

  • Previous
  • 1…
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • Next
RSS
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Meta

  • Privacy Policy
  • Intellectual Property
  • Safe Harbor Statement
  • HIPAA Policy
  • Web Feedback

Contact us

Enzo Biochem Executive Offices
81 Executive Blvd, Suite 3
Farmingdale, NY
11735
USA

212-583-0100

info@enzo.com

Copyright ©2023 Enzo Biochem Inc.